BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10390232)

  • 1. Comparative efficacies of liposomal amikacin (MiKasome) plus oxacillin versus conventional amikacin plus oxacillin in experimental endocarditis induced by Staphylococcus aureus: microbiological and echocardiographic analyses.
    Xiong YQ; Kupferwasser LI; Zack PM; Bayer AS
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1737-42. PubMed ID: 10390232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.
    Pefanis A; Thauvin-Eliopoulos C; Eliopoulos GM; Moellering RC
    Antimicrob Agents Chemother; 1993 Mar; 37(3):507-11. PubMed ID: 8460919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ampicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci.
    Ramos MC; Ing M; Kim E; Witt MD; Bayer AS
    Antimicrob Agents Chemother; 1996 Jan; 40(1):97-101. PubMed ID: 8787887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-Lactam-beta-lactamase-inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococci.
    Hirano L; Bayer AS
    Antimicrob Agents Chemother; 1991 Apr; 35(4):685-90. PubMed ID: 2069374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of oxacillin and ampicillin-sulbactam combination in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.
    Thauvin-Eliopoulos C; Rice LB; Eliopoulos GM; Moellering RC
    Antimicrob Agents Chemother; 1990 May; 34(5):728-32. PubMed ID: 2360813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of experimental staphylococcal endocarditis due to a strain with reduced susceptibility in vitro to vancomycin: efficacy of ampicillin-sulbactam.
    Backo M; Gaenger E; Burkart A; Chai YL; Bayer AS
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2565-8. PubMed ID: 10508047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telavancin in therapy of experimental aortic valve endocarditis in rabbits due to daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus.
    Xiong YQ; Hady WA; Bayer AS; Chen L; Kreiswirth BN; Yang SJ
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5528-33. PubMed ID: 22890759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin or vancomycin plus netilmicin for methicillin- and gentamicin-resistant Staphylococcus aureus aortic valve experimental endocarditis.
    Perdikaris G; Giamarellou H; Pefanis A; Donta I; Karayiannakos P
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2289-94. PubMed ID: 8619584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the Lysin Exebacase on Cardiac Vegetation Progression in a Rabbit Model of Methicillin-Resistant Staphylococcus aureus Endocarditis as Determined by Echocardiography.
    Shah SU; Xiong YQ; Abdelhady W; Iwaz J; Pak Y; Schuch R; Cassino C; Lehoux D; Bayer AS
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32340988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations.
    Bayer AS; Lam K
    J Infect Dis; 1985 Jan; 151(1):157-65. PubMed ID: 3965588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of methicillin, nafcillin, and oxacillin in therapy of Staphylococcus aureus endocarditis in rabbits.
    Egert J; Carrizosa J; Kaye D; Kobasa WD
    J Lab Clin Med; 1977 Jun; 89(6):1262-8. PubMed ID: 864305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics.
    Fox PM; Lampen RJ; Stumpf KS; Archer GL; Climo MW
    Antimicrob Agents Chemother; 2006 Sep; 50(9):2951-6. PubMed ID: 16940087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus.
    Chambers HF; Xiang Q; Liu ; Chow LL; Hackbarth C
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2742-6. PubMed ID: 10543757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of ceftazidime and aztreonam alone or in combination with amikacin in experimental left-sided Pseudomonas aeruginosa endocarditis.
    Pefanis A; Giamarellou H; Karayiannakos P; Donta I
    Antimicrob Agents Chemother; 1993 Feb; 37(2):308-13. PubMed ID: 8452362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility to thrombin-induced platelet microbicidal protein is associated with reduced disease progression and complication rates in experimental Staphylococcus aureus endocarditis: microbiological, histopathologic, and echocardiographic analyses.
    Kupferwasser LI; Yeaman MR; Shapiro SM; Nast CC; Bayer AS
    Circulation; 2002 Feb; 105(6):746-52. PubMed ID: 11839632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureus.
    Nicolau DP; Freeman CD; Nightingale CH; Coe CJ; Quintiliani R
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1515-8. PubMed ID: 7979281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal activity of oxacillin and glycopeptides against Staphylococcus aureus in patients with endocarditis: looking for a relationship between tolerance and outcome.
    Pasticci MB; Moretti A; Stagni G; Ravasio V; Soavi L; Raglio A; Vailati F; Cardaccia A; Santucci A; Papili R; Sgrelli A; Pallotto C; Baldelli F
    Ann Clin Microbiol Antimicrob; 2011 Jun; 10():26. PubMed ID: 21658248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis.
    Climo MW; Patron RL; Goldstein BP; Archer GL
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1355-60. PubMed ID: 9624475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous versus intermittent infusion of oxacillin for treatment of infective endocarditis caused by methicillin-susceptible Staphylococcus aureus.
    Hughes DW; Frei CR; Maxwell PR; Green K; Patterson JE; Crawford GE; Lewis JS
    Antimicrob Agents Chemother; 2009 May; 53(5):2014-9. PubMed ID: 19258261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of trovafloxacin, a new quinolone antibiotic, in experimental staphylococcal endocarditis due to oxacillin-resistant strains.
    Bayer AS; Li C; Ing M
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1837-41. PubMed ID: 9661030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.